HELIOS Kliniken

GeparPiPPa- A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC) (2022) Loibl S, Reinisch M, Denkert C, Schneeweiss A, Seiler S, Fasching P, Hanusch C, et al. Conference contribution Meeting Medical Need - Development of a High-Throughput Assay Using Pancreatic Cancer Patient Derived Organoids as a Tool for Personalized Medicine (2022) Sankarasubramanian S, Niethard M, Pilarsky C, Regenbrecht C, Wedeken L Conference contribution Neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy, followed by adjuvant pembrolizumab versus placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses from KEYNOTE-522 (2022) Schmid P, Cortes J, Dent R, Pusztai L, Mcarthur H, Kuemmel S, Bergh J, et al. Conference contribution Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response (2022) Loibl S, Schneeweiss A, Huober J, Braun M, Rey J, Blohmer JU, Furlanetto J, et al. Journal article Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS) (2022) Bielack SS, Blattmann C, Borkhardt A, Csóka M, Hassenpflug W, Kabíčková E, Kager L, et al. Journal article Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2022) Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, et al. Journal article, Letter Ticagrelor or Prasugrel in Patients with Acute Coronary Syndrome and High Bleeding Risk (2022) Lahu S, Presch A, Ndrepepa G, Menichelli M, Valina C, Hemetsberger R, Witzenbichler B, et al. Journal article Anti-SARS-CoV-2 vaccination immune response in MS patients: interim results of a multicentre, prospective cohort study (2022) Berthele A, Goedel C, Kallmann B, Kowarik M, Lehmann-Horn K, Marziniak M, Meyer C, et al. Conference contribution S2k Leitlinie: Diagnostik und Therapie des chronischen Pruritus (2022) Ständer S, Zeidler C, Augustin M, Darsow U, Kremer A, Legat FJ, Koschmieder S, et al. Journal article S2k guideline: Diagnosis and treatment of chronic pruritus (2022) Ständer S, Zeidler C, Augustin M, Darsow U, Kremer A, Legat FJ, Koschmieder S, et al. Journal article